Megan N. Young
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Chronic Subcutaneous Kisspeptin-10 Stimulates Gonadotropin Secretion for 12 Days in Healthy Men.
Journal: European journal of endocrinology
Published: April 24, 2026
Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice.
Journal: npj metabolic health and disease
Published: March 19, 2026
Bat power-metabolic profiling of the Egyptian fruit bat Rousettus aegyptiacus reveals distinctive cardiac adaptations.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy.
Journal: Cardiovascular research
Published: July 01, 2025
Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 07, 2025
Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype.
Journal: Cardiovascular diabetology
Published: December 19, 2024
Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans.
Journal: EBioMedicine
Published: November 13, 2024
Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential.
Journal: Annals of the New York Academy of Sciences
Published: September 17, 2024
New Model of Experimental Diabetic Cardiomyopathy Using Combination of Multiple Doses of Anomer-Equilibrated Streptozotocin and High-Fat Diet: Sex Matters.
Journal: Diabetes
Published: May 08, 2024
Last Updated: 09/26/2026